Loading...
NeoGenomics, Inc.
NEO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.29
$-0.13(-1.95%)
NeoGenomics, Inc. (NEO) Financial Performance & Income Statement Overview
Review NeoGenomics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.65%
↑ 11.65%
Operating Income Growth
14.51%
↑ 14.51%
Net Income Growth
10.51%
↑ 10.51%
Operating Cash Flow Growth
459.60%
↑ 459.60%
Operating Margin
-13.06%
↓ 13.06%
Gross Margin
43.79%
↑ 43.79%
Net Profit Margin
-11.54%
↓ 11.54%
ROE
-8.59%
↓ 8.59%
ROIC
-6.64%
↓ 6.64%
NeoGenomics, Inc. (NEO) Income Statement & Financial Overview
Review NeoGenomics, Inc.'s (NEO) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $168.03M | $172.00M | $167.82M | $164.50M |
| Cost of Revenue | $94.79M | $94.74M | $92.94M | $95.46M |
| Gross Profit | $73.25M | $77.26M | $74.88M | $69.04M |
| Gross Profit Ratio | $0.44 | $0.45 | $0.45 | $0.42 |
| R&D Expenses | $10.18M | $7.97M | $7.68M | $7.89M |
| SG&A Expenses | $90.89M | $85.98M | $87.38M | $81.55M |
| Operating Expenses | $101.07M | $95.66M | $95.07M | $89.44M |
| Total Costs & Expenses | $195.86M | $190.40M | $188.01M | $184.90M |
| Interest Income | -$3.72M | $4.33M | $4.67M | $4.59M |
| Interest Expense | $1.62M | $1.62M | $1.64M | $1.67M |
| Depreciation & Amortization | $0.00 | $18.19M | $17.98M | $18.11M |
| EBITDA | -$27.82M | $3.68M | $1.78M | $756000.00 |
| EBITDA Ratio | -$0.17 | $0.02 | $0.01 | $0.005 |
| Operating Income | -$27.82M | -$18.40M | -$21.20M | -$20.40M |
| Operating Income Ratio | -$0.17 | -$0.11 | -$0.13 | -$0.12 |
| Other Income/Expenses (Net) | $2.17M | $3.08M | $3.35M | $2.92M |
| Income Before Tax | -$25.66M | -$15.32M | -$17.85M | -$19.02M |
| Income Before Tax Ratio | -$0.15 | -$0.09 | -$0.11 | -$0.12 |
| Income Tax Expense | $266000.00 | -$804000.00 | -$150000.00 | -$375000.00 |
| Net Income | -$25.92M | -$15.32M | -$17.70M | -$18.64M |
| Net Income Ratio | -$0.15 | -$0.09 | -$0.11 | -$0.11 |
| EPS | -$0.20 | -$0.12 | -$0.14 | -$0.15 |
| Diluted EPS | -$0.20 | -$0.12 | -$0.14 | -$0.15 |
| Weighted Avg Shares Outstanding | $127.38M | $126.66M | $126.95M | $126.41M |
| Weighted Avg Shares Outstanding (Diluted) | $127.38M | $126.66M | $126.95M | $126.41M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan